Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Gennex Laboratories Ltd

NSE: GENNEX · BSE: 531739 · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹10.10
Market cap: ₹245.4 Cr
Revenue (annual): ₹172.7 Cr
Net profit (annual): ₹20.98 Cr
P/E (TTM): 10.4×Sector 50.4×
Promoter holding: 23.63%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Business Update 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 Aug 2026 16:56 IST BSE

Financial Results

Gennex Laboratories Q1 FY27 Results: Net Profit ₹4.7 Cr, Down 6.0% YoY

Gennex Laboratories Ltd reported revenue from operations of ₹39.8 Cr (+16.4% YoY) and net profit of ₹4.7 Cr (-6.0% YoY) for Q1 FY27.

Key figure: Net profit ₹4.7 Cr · -6.0% YoY

Open full results → Read the filing ↗

30 May 2026 19:45 IST BSE

Financial Results

Gennex Laboratories Q4 FY26 Results: Net Profit ₹4.5 Cr, Up 45.2% YoY

Gennex Laboratories Ltd reported revenue from operations of ₹61 Cr (+51.4% YoY) and net profit of ₹4.5 Cr (+45.2% YoY) for Q4 FY26.

Key figure: Net profit ₹4.5 Cr · +45.2% YoY

Open full results → Read the filing ↗